MoneyWorks4Me

Orchid Pharma - Quaterly Results

10 Aug 2023 Evaluate
The sales moved up 39.65% to Rs. 1829.20 millions for the June 2023 quarter as compared to Rs. 1309.88 millions during the year-ago period.The Total Profit for the quarter ended June 2023 of Rs. 107.75 millions grew from Rs.-140.88 millionsThe company reported a good operating profit of 240.28 millions compared to 153.81 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 1829.20 1309.88 39.65 1829.20 1309.88 39.65 6658.98 5569.74 19.56
Other Income 18.86 29.31 -35.65 18.86 29.31 -35.65 194.31 90.03 115.83
PBIDT 240.28 153.81 56.22 240.28 153.81 56.22 1030.49 662.62 55.52
Interest 55.45 78.40 -29.27 55.45 78.40 -29.27 322.26 320.12 0.67
PBDT 184.83 75.41 145.10 184.83 75.41 145.10 1100.33 342.50 221.26
Depreciation 77.08 216.29 -64.36 77.08 216.29 -64.36 547.86 870.21 -37.04
PBT 107.75 -140.88 -176.48 107.75 -140.88 -176.48 552.47 -527.71 -204.69
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 107.75 -140.88 -176.48 107.75 -140.88 -176.48 552.47 -527.71 -204.69
Equity 507.19 408.16 24.26 507.19 408.16 24.26 408.16 408.16 0.00
PBIDTM(%) 13.14 11.74 11.87 13.14 11.74 11.87 15.48 11.90 30.08
Peers
Company Name CMP
Sun Pharma. Inds. 1851.50
Dr. Reddys Labs. 1140.50
Cipla 1357.95
Lupin 2041.60
Zydus Lifesciences 1098.40
View more..